Table 2.
Comparison of Outcome Parameters (Adherence and Clinical Outcomes) Among Groups
| Outcomes | Subcategories | All Patients (n=931) n(%) |
UC Group (n=466) n(%) |
PC Group (n=465) n(%) |
p-value (UC vs PC) |
|---|---|---|---|---|---|
| ETR | ETR (NA) | 97 (10.4%) | 57 (12.2%) | 40 (8.6%) | |
| Failed at ETR | 16 (1.7%) | 9 (1.9%) | 7 (1.5%) | ||
| ETR achieved | 818 (87.9%) | 400 (85.8%) | 418 (89.9%) | 0.163 | |
| SVR12 | Did not have SVR | 192 (20.6%) | 134 (28.8%) | 58 (12.5%) | |
| Failed | 16 (1.7%) | 9 (1.9%) | 7 (1.5%) | ||
| SVR achieved | 723 (77.7%) | 323 (69.3%) | 400 (86.0%) | 0 | |
| Adherence (pharmacy refills) | ≤60% | 115 (12.4%) | 68 (14.6%) | 17 (3.7%) | 0 |
| 61%–79% | 41 (4.4%) | 35 (7.5%) | 36 (7.7%) | ||
| ≥80% | 775 (83.2%) | 363 (77.9%) | 412 (88.6%) | 0 |
Notes: p<0.05 considered significant.
Abbreviations: HCV, hepatitis C virus; CHC, chronic hepatitis C; ETR, end-of-treatment response; NA, not available; SVR12, sustained virological response at 12 weeks after end of treatment; UC, usual care; PC, pharmaceutical care.